Global Skin Active Delivery System Market Research Report 2024

Publication ID:

PB508247617

Publication Date:

August 21, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

IT Services [2]

Computing & Electronics [3]

Description:

The global Skin Active Delivery System market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Skin Active Delivery System is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Skin Active Delivery System is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Skin Active Delivery System in Drug is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Skin Active Delivery System include KINDEVA, Zosano Pharma, Becton-Dickinson(BD)Technologies, Corium, Nitto, Valeritas, Nanopass Technologies, TheraJect, Inc and Vaxxas, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Skin Active Delivery System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Skin Active Delivery System.
Report Scope
The Skin Active Delivery System market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Skin Active Delivery System market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Skin Active Delivery System companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
KINDEVA
Zosano Pharma
Becton-Dickinson(BD)Technologies
Corium
Nitto
Valeritas
Nanopass Technologies
TheraJect, Inc
Vaxxas
Microdermics
Lohmann Therapie-Systeme AG
BASF
3M
Evonik Personal Care
Vantage Personal Care
Minerals Technologies
Bicosome
Segment by Type
Microcapsules
Base Oil
Microneedle Technology
Segment by Application
Drug
Cosmetic
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Skin Active Delivery System companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Skin Active Delivery System Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Microcapsules
1.2.3 Base Oil
1.2.4 Microneedle Technology
1.3 Market by Application
1.3.1 Global Skin Active Delivery System Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Drug
1.3.3 Cosmetic
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Skin Active Delivery System Market Perspective (2019-2030)
2.2 Skin Active Delivery System Growth Trends by Region
2.2.1 Global Skin Active Delivery System Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Skin Active Delivery System Historic Market Size by Region (2019-2024)
2.2.3 Skin Active Delivery System Forecasted Market Size by Region (2025-2030)
2.3 Skin Active Delivery System Market Dynamics
2.3.1 Skin Active Delivery System Industry Trends
2.3.2 Skin Active Delivery System Market Drivers
2.3.3 Skin Active Delivery System Market Challenges
2.3.4 Skin Active Delivery System Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Skin Active Delivery System Players by Revenue
3.1.1 Global Top Skin Active Delivery System Players by Revenue (2019-2024)
3.1.2 Global Skin Active Delivery System Revenue Market Share by Players (2019-2024)
3.2 Global Skin Active Delivery System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Skin Active Delivery System Revenue
3.4 Global Skin Active Delivery System Market Concentration Ratio
3.4.1 Global Skin Active Delivery System Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Skin Active Delivery System Revenue in 2023
3.5 Skin Active Delivery System Key Players Head office and Area Served
3.6 Key Players Skin Active Delivery System Product Solution and Service
3.7 Date of Enter into Skin Active Delivery System Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Skin Active Delivery System Breakdown Data by Type
4.1 Global Skin Active Delivery System Historic Market Size by Type (2019-2024)
4.2 Global Skin Active Delivery System Forecasted Market Size by Type (2025-2030)
5 Skin Active Delivery System Breakdown Data by Application
5.1 Global Skin Active Delivery System Historic Market Size by Application (2019-2024)
5.2 Global Skin Active Delivery System Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Skin Active Delivery System Market Size (2019-2030)
6.2 North America Skin Active Delivery System Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Skin Active Delivery System Market Size by Country (2019-2024)
6.4 North America Skin Active Delivery System Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Skin Active Delivery System Market Size (2019-2030)
7.2 Europe Skin Active Delivery System Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Skin Active Delivery System Market Size by Country (2019-2024)
7.4 Europe Skin Active Delivery System Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Skin Active Delivery System Market Size (2019-2030)
8.2 Asia-Pacific Skin Active Delivery System Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Skin Active Delivery System Market Size by Region (2019-2024)
8.4 Asia-Pacific Skin Active Delivery System Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Skin Active Delivery System Market Size (2019-2030)
9.2 Latin America Skin Active Delivery System Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Skin Active Delivery System Market Size by Country (2019-2024)
9.4 Latin America Skin Active Delivery System Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Skin Active Delivery System Market Size (2019-2030)
10.2 Middle East & Africa Skin Active Delivery System Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Skin Active Delivery System Market Size by Country (2019-2024)
10.4 Middle East & Africa Skin Active Delivery System Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 KINDEVA
11.1.1 KINDEVA Company Detail
11.1.2 KINDEVA Business Overview
11.1.3 KINDEVA Skin Active Delivery System Introduction
11.1.4 KINDEVA Revenue in Skin Active Delivery System Business (2019-2024)
11.1.5 KINDEVA Recent Development
11.2 Zosano Pharma
11.2.1 Zosano Pharma Company Detail
11.2.2 Zosano Pharma Business Overview
11.2.3 Zosano Pharma Skin Active Delivery System Introduction
11.2.4 Zosano Pharma Revenue in Skin Active Delivery System Business (2019-2024)
11.2.5 Zosano Pharma Recent Development
11.3 Becton-Dickinson(BD)Technologies
11.3.1 Becton-Dickinson(BD)Technologies Company Detail
11.3.2 Becton-Dickinson(BD)Technologies Business Overview
11.3.3 Becton-Dickinson(BD)Technologies Skin Active Delivery System Introduction
11.3.4 Becton-Dickinson(BD)Technologies Revenue in Skin Active Delivery System Business (2019-2024)
11.3.5 Becton-Dickinson(BD)Technologies Recent Development
11.4 Corium
11.4.1 Corium Company Detail
11.4.2 Corium Business Overview
11.4.3 Corium Skin Active Delivery System Introduction
11.4.4 Corium Revenue in Skin Active Delivery System Business (2019-2024)
11.4.5 Corium Recent Development
11.5 Nitto
11.5.1 Nitto Company Detail
11.5.2 Nitto Business Overview
11.5.3 Nitto Skin Active Delivery System Introduction
11.5.4 Nitto Revenue in Skin Active Delivery System Business (2019-2024)
11.5.5 Nitto Recent Development
11.6 Valeritas
11.6.1 Valeritas Company Detail
11.6.2 Valeritas Business Overview
11.6.3 Valeritas Skin Active Delivery System Introduction
11.6.4 Valeritas Revenue in Skin Active Delivery System Business (2019-2024)
11.6.5 Valeritas Recent Development
11.7 Nanopass Technologies
11.7.1 Nanopass Technologies Company Detail
11.7.2 Nanopass Technologies Business Overview
11.7.3 Nanopass Technologies Skin Active Delivery System Introduction
11.7.4 Nanopass Technologies Revenue in Skin Active Delivery System Business (2019-2024)
11.7.5 Nanopass Technologies Recent Development
11.8 TheraJect, Inc
11.8.1 TheraJect, Inc Company Detail
11.8.2 TheraJect, Inc Business Overview
11.8.3 TheraJect, Inc Skin Active Delivery System Introduction
11.8.4 TheraJect, Inc Revenue in Skin Active Delivery System Business (2019-2024)
11.8.5 TheraJect, Inc Recent Development
11.9 Vaxxas
11.9.1 Vaxxas Company Detail
11.9.2 Vaxxas Business Overview
11.9.3 Vaxxas Skin Active Delivery System Introduction
11.9.4 Vaxxas Revenue in Skin Active Delivery System Business (2019-2024)
11.9.5 Vaxxas Recent Development
11.10 Microdermics
11.10.1 Microdermics Company Detail
11.10.2 Microdermics Business Overview
11.10.3 Microdermics Skin Active Delivery System Introduction
11.10.4 Microdermics Revenue in Skin Active Delivery System Business (2019-2024)
11.10.5 Microdermics Recent Development
11.11 Lohmann Therapie-Systeme AG
11.11.1 Lohmann Therapie-Systeme AG Company Detail
11.11.2 Lohmann Therapie-Systeme AG Business Overview
11.11.3 Lohmann Therapie-Systeme AG Skin Active Delivery System Introduction
11.11.4 Lohmann Therapie-Systeme AG Revenue in Skin Active Delivery System Business (2019-2024)
11.11.5 Lohmann Therapie-Systeme AG Recent Development
11.12 BASF
11.12.1 BASF Company Detail
11.12.2 BASF Business Overview
11.12.3 BASF Skin Active Delivery System Introduction
11.12.4 BASF Revenue in Skin Active Delivery System Business (2019-2024)
11.12.5 BASF Recent Development
11.13 3M
11.13.1 3M Company Detail
11.13.2 3M Business Overview
11.13.3 3M Skin Active Delivery System Introduction
11.13.4 3M Revenue in Skin Active Delivery System Business (2019-2024)
11.13.5 3M Recent Development
11.14 Evonik Personal Care
11.14.1 Evonik Personal Care Company Detail
11.14.2 Evonik Personal Care Business Overview
11.14.3 Evonik Personal Care Skin Active Delivery System Introduction
11.14.4 Evonik Personal Care Revenue in Skin Active Delivery System Business (2019-2024)
11.14.5 Evonik Personal Care Recent Development
11.15 Vantage Personal Care
11.15.1 Vantage Personal Care Company Detail
11.15.2 Vantage Personal Care Business Overview
11.15.3 Vantage Personal Care Skin Active Delivery System Introduction
11.15.4 Vantage Personal Care Revenue in Skin Active Delivery System Business (2019-2024)
11.15.5 Vantage Personal Care Recent Development
11.16 Minerals Technologies
11.16.1 Minerals Technologies Company Detail
11.16.2 Minerals Technologies Business Overview
11.16.3 Minerals Technologies Skin Active Delivery System Introduction
11.16.4 Minerals Technologies Revenue in Skin Active Delivery System Business (2019-2024)
11.16.5 Minerals Technologies Recent Development
11.17 Bicosome
11.17.1 Bicosome Company Detail
11.17.2 Bicosome Business Overview
11.17.3 Bicosome Skin Active Delivery System Introduction
11.17.4 Bicosome Revenue in Skin Active Delivery System Business (2019-2024)
11.17.5 Bicosome Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

KINDEVA
Zosano Pharma
Becton-Dickinson(BD)Technologies
Corium
Nitto
Valeritas
Nanopass Technologies
TheraJect, Inc
Vaxxas
Microdermics
Lohmann Therapie-Systeme AG
BASF
3M
Evonik Personal Care
Vantage Personal Care
Minerals Technologies
Bicosome

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂